Drug development
and diagnostics
Choose the relevant keywords from the list to search for research groups on those specific areas. As the search is cumulative, choose only a few keywords for a general search and more keywords for more refined search. To see all research groups, click the selection underneath the list.
Auria Biobank
Main categories: Diagnostics, Drug discovery
Auria Biobank is a hospital integrated clinical biobank operating in Turku. It is jointly owned by University of Turku and Hospital districts of Southwest Finland, Satakunta and Vaasa. The catchment population is the area is approximately 900 000 people. Auria biobank was authorized to operate in March 2014. The aim of Auria is to provide a research infrastructure for both academic investigators and for company R&D. Auria has ongoing biobank projects with most big Pharma companies as well as academic research groups.
Biobank research plays a key role, for example in promoting personalized medicine, understanding the underlying diseases, and examining the effectiveness of therapies. The results from biobank studies will return to the biobank to add value to samples and to be used in new studies.
Auria has a collection of over one million FFPE tissue samples and ongoing collection of tissue and blood samples. Clinical data generated as part of the diagnosis, treatment, and follow-up of the patients is obtained from the hospital’s electronic health record systems and can be linked to the samples. Clinical data is stored in the biobank sample and data register in an encoded anonymized manner, which protects the privacy of the sample donors while making it possible to link the data from all sources to individual patients.
Drug development and diagnostics is a common research profiling area of the University of Turku and Åbo Akademi University funded by the Academy of Finland. This website is a part of this joint initiative bringing together all information that is related to drug discovery and development or diagnostics from both universities.
